Treatments for Young-onset Parkinson disease

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.

Report missing data

FDA-approved treatments (3)

VYALEV
FOSCARBIDOPA/FOSLEVODOPA
AbbVie Inc.
Gocovri
Amantadine hydrochloride
Adamas Pharmaceuticals, Inc.
Onapgo
apomorphine hydrochloride
MDD US Operations, LLC

Patient support programs (1)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

VYALEV

AbbVie Inc.

VYALEV Patient Support (AbbVie Patient Assistance)

Patient Assistance

Manufacturer Program

Accepting applications

Apply

More about Young-onset Parkinson disease

Disease overview →
Specialists →
Clinical trials →